Amar Kelkar

Company: Dana-Farber Cancer Institute

Job title: Stem Cell Transplantation Physician

Seminars:

Assessing Value- & Cost-effectiveness: How to Compare Novel Cell and Gene Therapies with Current Standards of Care to Improve Decision-Making 9:30 am

Developing a value framework to justify the benefits behind the pricing. Analyzing cost-effectiveness, i.e., balancing the therapy's cost relative to its benefits and outcomes achieved, considering factors like quality-adjusted life years gained How does each particular C&G treatment impact the overall treatment paradigm and economy?Read more

day: Conference Day Two